Increasing value and reducing waste: Addressing inaccessible research

An Wen Chan, Fujian Song, Andrew Vickers, Tom Jefferson, Kay Dickersin, Peter C. Gøtzsche, Harlan M. Krumholz, Davina Ghersi, H. Bart Van Der Worp

Research output: Contribution to journalArticle

Abstract

The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and participant-level datasets. However, protocols, full study reports, and participant-level datasets are rarely available, and journal reports are available for only half of all studies and are plagued by selective reporting of methods and results. Furthermore, information provided in study protocols and reports varies in quality and is often incomplete. When full information about studies is inaccessible, billions of dollars in investment are wasted, bias is introduced, and research and care of patients are detrimentally aff ected. To help to improve this situation at a systemic level, three main actions are warranted. First, academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets. Second, standards for the content of protocols and full study reports and for data sharing practices should be rigorously developed and adopted for all types of health research. Finally, journals, funders, sponsors, research ethics committees, regulators, and legislators should endorse and enforce policies supporting study registration and wide availability of journal reports, full study reports, and participant-level datasets.

Original languageEnglish (US)
Pages (from-to)257-266
Number of pages10
JournalThe Lancet
Volume383
Issue number9913
DOIs
StatePublished - 2014

Fingerprint

Research
Information Dissemination
Research Ethics Committees
Health
Reward
Patient Care
Research Personnel
Datasets

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chan, A. W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., ... Van Der Worp, H. B. (2014). Increasing value and reducing waste: Addressing inaccessible research. The Lancet, 383(9913), 257-266. https://doi.org/10.1016/S0140-6736(13)62296-5

Increasing value and reducing waste : Addressing inaccessible research. / Chan, An Wen; Song, Fujian; Vickers, Andrew; Jefferson, Tom; Dickersin, Kay; Gøtzsche, Peter C.; Krumholz, Harlan M.; Ghersi, Davina; Van Der Worp, H. Bart.

In: The Lancet, Vol. 383, No. 9913, 2014, p. 257-266.

Research output: Contribution to journalArticle

Chan, AW, Song, F, Vickers, A, Jefferson, T, Dickersin, K, Gøtzsche, PC, Krumholz, HM, Ghersi, D & Van Der Worp, HB 2014, 'Increasing value and reducing waste: Addressing inaccessible research', The Lancet, vol. 383, no. 9913, pp. 257-266. https://doi.org/10.1016/S0140-6736(13)62296-5
Chan, An Wen ; Song, Fujian ; Vickers, Andrew ; Jefferson, Tom ; Dickersin, Kay ; Gøtzsche, Peter C. ; Krumholz, Harlan M. ; Ghersi, Davina ; Van Der Worp, H. Bart. / Increasing value and reducing waste : Addressing inaccessible research. In: The Lancet. 2014 ; Vol. 383, No. 9913. pp. 257-266.
@article{206ac8511e894ebe87ef35acbc1cd522,
title = "Increasing value and reducing waste: Addressing inaccessible research",
abstract = "The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and participant-level datasets. However, protocols, full study reports, and participant-level datasets are rarely available, and journal reports are available for only half of all studies and are plagued by selective reporting of methods and results. Furthermore, information provided in study protocols and reports varies in quality and is often incomplete. When full information about studies is inaccessible, billions of dollars in investment are wasted, bias is introduced, and research and care of patients are detrimentally aff ected. To help to improve this situation at a systemic level, three main actions are warranted. First, academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets. Second, standards for the content of protocols and full study reports and for data sharing practices should be rigorously developed and adopted for all types of health research. Finally, journals, funders, sponsors, research ethics committees, regulators, and legislators should endorse and enforce policies supporting study registration and wide availability of journal reports, full study reports, and participant-level datasets.",
author = "Chan, {An Wen} and Fujian Song and Andrew Vickers and Tom Jefferson and Kay Dickersin and G{\o}tzsche, {Peter C.} and Krumholz, {Harlan M.} and Davina Ghersi and {Van Der Worp}, {H. Bart}",
year = "2014",
doi = "10.1016/S0140-6736(13)62296-5",
language = "English (US)",
volume = "383",
pages = "257--266",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9913",

}

TY - JOUR

T1 - Increasing value and reducing waste

T2 - Addressing inaccessible research

AU - Chan, An Wen

AU - Song, Fujian

AU - Vickers, Andrew

AU - Jefferson, Tom

AU - Dickersin, Kay

AU - Gøtzsche, Peter C.

AU - Krumholz, Harlan M.

AU - Ghersi, Davina

AU - Van Der Worp, H. Bart

PY - 2014

Y1 - 2014

N2 - The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and participant-level datasets. However, protocols, full study reports, and participant-level datasets are rarely available, and journal reports are available for only half of all studies and are plagued by selective reporting of methods and results. Furthermore, information provided in study protocols and reports varies in quality and is often incomplete. When full information about studies is inaccessible, billions of dollars in investment are wasted, bias is introduced, and research and care of patients are detrimentally aff ected. To help to improve this situation at a systemic level, three main actions are warranted. First, academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets. Second, standards for the content of protocols and full study reports and for data sharing practices should be rigorously developed and adopted for all types of health research. Finally, journals, funders, sponsors, research ethics committees, regulators, and legislators should endorse and enforce policies supporting study registration and wide availability of journal reports, full study reports, and participant-level datasets.

AB - The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and participant-level datasets. However, protocols, full study reports, and participant-level datasets are rarely available, and journal reports are available for only half of all studies and are plagued by selective reporting of methods and results. Furthermore, information provided in study protocols and reports varies in quality and is often incomplete. When full information about studies is inaccessible, billions of dollars in investment are wasted, bias is introduced, and research and care of patients are detrimentally aff ected. To help to improve this situation at a systemic level, three main actions are warranted. First, academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets. Second, standards for the content of protocols and full study reports and for data sharing practices should be rigorously developed and adopted for all types of health research. Finally, journals, funders, sponsors, research ethics committees, regulators, and legislators should endorse and enforce policies supporting study registration and wide availability of journal reports, full study reports, and participant-level datasets.

UR - http://www.scopus.com/inward/record.url?scp=84892614609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892614609&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(13)62296-5

DO - 10.1016/S0140-6736(13)62296-5

M3 - Article

C2 - 24411650

AN - SCOPUS:84892614609

VL - 383

SP - 257

EP - 266

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9913

ER -